Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Brain fluorodeoxyglucose positron emission tomography (¹⁸FDG PET) in patients with acute thallium intoxication.

Liu CH, Lin KJ, Wang HM, Kuo HC, Chuang WL, Weng YH, Shih TS, Huang CC.

Clin Toxicol (Phila). 2013 Mar;51(3):167-73. doi: 10.3109/15563650.2013.773008.

PMID:
23473461
3.

Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.

Yanase D, Matsunari I, Yajima K, Chen W, Fujikawa A, Nishimura S, Matsuda H, Yamada M.

Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):794-805. Epub 2005 Mar 10.

PMID:
15759148
4.

Evaluation of myocardial viability following acute myocardial infarction using 201Tl SPECT after thallium-glucose-insulin infusion--comparison with 18F-FDG positron emission tomography.

Toyama T, Hoshizaki H, Seki R, Isobe N, Oshima S, Taniguchi K, Higuchi K, Seki H, Hatori T, Kurabayashi M, Endo K.

Ann Nucl Med. 2004 Sep;18(6):463-8.

PMID:
15515744
5.

Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study.

O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, Menon DK, Pickard JD, Hutchinson PJ.

Acta Neurochir Suppl. 2005;95:165-8.

PMID:
16463843
7.

Long-term neurotoxic effects of dimethylamine borane intoxication.

Liu CH, Wang HM, Lin KJ, Kuo HC, Weng YH, Shih TS, Huang CC.

J Neurol Sci. 2012 Aug 15;319(1-2):147-51. doi: 10.1016/j.jns.2012.05.013. Epub 2012 May 26.

PMID:
22633443
8.

Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.

Huang C, Ravdin LD, Nirenberg MJ, Piboolnurak P, Severt L, Maniscalco JS, Solnes L, Dorfman BJ, Henchcliffe C.

Dement Geriatr Cogn Disord. 2013;35(3-4):183-96. doi: 10.1159/000345987. Epub 2013 Feb 22.

PMID:
23445555
9.

The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy.

Weitemeyer L, Kellinghaus C, Weckesser M, Matheja P, Loddenkemper T, Schuierer G, Schober O, Ringelstein EB, Lüdemann P.

Epilepsia. 2005 Oct;46(10):1654-60.

10.

Frontal network syndrome testing: clinical tests and positron emission tomography brain imaging help distinguish the 3 most common dementia subtypes.

Hoffmann M.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):477-84. doi: 10.1177/1533317513488920. Epub 2013 May 15.

PMID:
23677732
11.

Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.

Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergström M, Tsukada H, Hartvig P, Långström B.

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):85-95. Epub 2002 Oct 26. Erratum in: Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):186.

PMID:
12483414
12.
13.

Hemisphere-specific episodic memory networks in the human brain: a correlation study between intracarotid amobarbital test and [(18)F]FDG-PET.

Akanuma N, Reed LJ, Marsden PK, Jarosz J, Adachi N, Hallett WA, Alarcón G, Morris RG, Koutroumanidis M.

J Cogn Neurosci. 2009 Mar;21(3):605-22. doi: 10.1162/jocn.2009.21035.

PMID:
18564051
14.

FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.

Palmedo H, Urbach H, Bender H, Schlegel U, Schmidt-Wolf IG, Matthies A, Linnebank M, Joe A, Bucerius J, Biersack HJ, Pels H.

Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):164-8. Epub 2005 Oct 12.

PMID:
16220304
15.

Brain positron emission tomography in preterm and term newborn infants.

Shi Y, Jin RB, Zhao JN, Tang SF, Li HQ, Li TY.

Early Hum Dev. 2009 Jul;85(7):429-32. doi: 10.1016/j.earlhumdev.2009.02.002. Epub 2009 Mar 6.

PMID:
19269116
16.

Evaluation of therapeutic response to donepezil by positron emission tomography.

Shimada A, Hashimoto H, Kawabe J, Higashiyama S, Kai T, Kataoka K, Tagawa R, Kawarada Y, Nakanishi A, Inoue K, Shiomi S, Kiriike N.

Osaka City Med J. 2011 Jun;57(1):11-9.

PMID:
22106763
17.

Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.

Kalbe E, Voges J, Weber T, Haarer M, Baudrexel S, Klein JC, Kessler J, Sturm V, Heiss WD, Hilker R.

Neurology. 2009 Jan 6;72(1):42-9. doi: 10.1212/01.wnl.0000338536.31388.f0.

PMID:
19122029
18.
19.

Necessity of a uniform start for scanning after FDG injection in brain PET study.

Ishii K, Higashi Y, Tabata M, Miyaishi M, Mizutani T, Sasaki M.

Ann Nucl Med. 2006 May;20(4):329-31.

PMID:
16856579
20.

Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.

Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K.

J Nucl Med. 1996 Mar;37(3):457-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk